Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies

We aimed to determine whether uncertainties identified by the European Medicines Agency (EMA) were associated with negative relative effectiveness assessments (REAs) and negative overall reimbursement recommendations by national health technology assessment (HTA) agencies. Therefore, we identified a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W. L., Hoekman, Jarno, van der Elst, Menno E., Leufkens, Hubert G. M., Klungel, Olaf H., Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301545/
https://www.ncbi.nlm.nih.gov/pubmed/33786991
http://dx.doi.org/10.1111/cts.13027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301545/
https://www.ncbi.nlm.nih.gov/pubmed/33786991
http://dx.doi.org/10.1111/cts.13027

Ejemplares similares